Russel E. Kaufman, M.D., Appointed Director and CEO of The Wistar Institute

Russel E. Kaufman, M.D., Appointed Director and CEO of The Wistar Institute

April 9, 2002

(PHILADELPHIA - April 10, 2002) - Russel E. Kaufman, M.D., has been appointed the next director and CEO of The Wistar Institute, an independent nonprofit biomedical research center in Philadelphia. The announcement was made today by Robert A. Fox, a member and former president of Wistar's Board of Managers and head of the Institute's search committee for a director. Dr. Kaufman will assume his new responsibilities on June 10.

"After a long search during which we interviewed many candidates, we are delighted to welcome a physician, research scientist, and administrator with Dr. Kaufman's unique skills to The Wistar Institute," says Mr. Fox, who is also chairman and CEO of the investment firm R.A.F. Industries Inc. "As director, Dr. Kaufman's vision for the future of cancer research, which springs from his broad experience in both the clinic and the laboratory, will ensure that Wistar remains at the leading edge of biomedical science."

Dr. Kaufman, 56, is currently vice dean for education and academic affairs for the Duke University School of Medicine and associate vice chancellor for academic affairs for the Duke University Health System. He is a professor of medicine and biochemistry at Duke, and his research interests focus on the genetics of blood diseases and cancer.

"I'm excited to be given the opportunity to shape the direction of cancer research at one of the finest basic research institutions in the country," Dr. Kaufman says. "The Wistar Institute has a great tradition and outstanding scientists, and it resides in a rich intellectual environment in Philadelphia. Also, as an independent basic science center, Wistar is well positioned to respond quickly to new opportunities in cancer research and is able to sharply focus its efforts to attack and understand problems in cancer biology."

With long-standing interests in both basic and applied cancer research, Dr. Kaufman has served as a scientific advisor in these areas to the National Institutes of Health, the American Cancer Society, and a number of other organizations. He has received awards for his work from the March of Dimes, the Leukemia and Lymphoma Society of America, the Arthritis Foundation, and others.

At Duke, he led a restructuring of its clinical research infrastructure, which has been acknowledged as a national model. He is often called upon by national organizations to participate in discussions concerning human-subject protections in clinical trials and the need for appropriate balances between academic and commercial interests to maintain the integrity of the research process.

Dr. Kaufman has extensive experience in national leadership roles in research and medical organizations. He served as president of the Association of Subspecialty Professors and chair of the Association of Hematology and Oncology Program Directors. He has been active in many internal medicine organizations, including the American Board of Internal Medicine and the Federated Council of Internal Medicine. He has served on several taskforces at the Association of American Medical Colleges.

At Ohio State University, Dr. Kaufman majored in zoology and biochemistry, graduating with a B.S. in 1968. He attended Ohio State University's College of Medicine and was awarded his M.D. in 1973. From 1973 to 1978, he served his medical residency at the Duke University Medical Center and was chief resident from 1977 to 1978. His postgraduate training included a hematology/oncology fellowship from 1976 to 1977 at Duke and training as a research hematologist at the National Institutes of Health in Bethesda, MD, from 1978 to 1980.

In 1980, Dr. Kaufman was appointed assistant professor of medicine at Duke and, in 1984, assistant professor of biochemistry. In 1987, he was promoted to associate professor of medicine and, in 1995, to associate professor of biochemistry. In 1994, Dr. Kaufman advanced to professor of medicine and, in 2001, to professor of biochemistry, his current academic positions.

He was chief of the division of hematology/oncology at Duke University Medical Center from 1990 to 1995, and, from 1995 to 1998, chief of the division of medical oncology and transplantation. He was vice chair of academic programs and development for the department of medicine at Duke from 1995 to 1999. From 1998 to 1999, Dr. Kaufman was associate dean for special programs for Duke's School of Medicine and associate chief of staff for education at the Veterans Administration Medical Center in Durham, NC. He served as vice dean for education at Duke's School of Medicine from 1999 to 2000 and was promoted to vice dean for education and academic affairs, his current position at the School, in 2000.

Dr. Kaufman and his wife, Jane, have two grown children.

The Wistar Institute is an independent nonprofit biomedical research institution dedicated to discovering the causes and cures for major diseases, including cancer, cardiovascular disease, autoimmune disorders, and infectious diseases. Founded in 1892 as the first institution of its kind in the nation, The Wistar Institute today is a National Cancer Institute-designated Cancer Center - one of only eight focused on basic research. Discoveries at Wistar have led to the development of vaccines for such diseases as rabies and rubella, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools.

###